These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation. Kure I; Nishiumi S; Nishitani Y; Tanoue T; Ishida T; Mizuno M; Fujita T; Kutsumi H; Arita M; Azuma T; Yoshida M J Pharmacol Exp Ther; 2010 Feb; 332(2):541-8. PubMed ID: 19846590 [TBL] [Abstract][Full Text] [Related]
23. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells. Dechecchi MC; Nicolis E; Bezzerri V; Vella A; Colombatti M; Assael BM; Mettey Y; Borgatti M; Mancini I; Gambari R; Becq F; Cabrini G Am J Respir Cell Mol Biol; 2007 May; 36(5):615-24. PubMed ID: 17197571 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of IL-8 release from CFTR-deficient lung epithelial cells following pre-treatment with fenretinide. Vilela RM; Lands LC; Meehan B; Kubow S Int Immunopharmacol; 2006 Nov; 6(11):1651-64. PubMed ID: 16979119 [TBL] [Abstract][Full Text] [Related]
25. The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity. Fiorotto R; Villani A; Kourtidis A; Scirpo R; Amenduni M; Geibel PJ; Cadamuro M; Spirli C; Anastasiadis PZ; Strazzabosco M Hepatology; 2016 Dec; 64(6):2118-2134. PubMed ID: 27629435 [TBL] [Abstract][Full Text] [Related]
26. Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice. Saadane A; Soltys J; Berger M J Allergy Clin Immunol; 2005 Feb; 115(2):405-11. PubMed ID: 15696103 [TBL] [Abstract][Full Text] [Related]
27. CFTR depletion results in changes in fatty acid composition and promotes lipogenesis in intestinal Caco 2/15 cells. Mailhot G; Rabasa-Lhoret R; Moreau A; Berthiaume Y; Levy E PLoS One; 2010 May; 5(5):e10446. PubMed ID: 20463919 [TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory and corticosteroid-enhancing actions of vitamin D in monocytes of patients with steroid-resistant and those with steroid-sensitive asthma. Zhang Y; Leung DY; Goleva E J Allergy Clin Immunol; 2014 Jun; 133(6):1744-52.e1. PubMed ID: 24418482 [TBL] [Abstract][Full Text] [Related]
29. Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis. Villella VR; Esposito S; Ferrari E; Monzani R; Tosco A; Rossin F; Castaldo A; Silano M; Marseglia GL; Romani L; Barlev NA; Piacentini M; Raia V; Kroemer G; Maiuri L Cell Death Dis; 2019 Mar; 10(4):258. PubMed ID: 30874543 [TBL] [Abstract][Full Text] [Related]
30. Exploring and Enhancing the Anti-Inflammatory Properties of Polymeric Formula. Alhagamhmad MH; Day AS; Lemberg DA; Leach ST JPEN J Parenter Enteral Nutr; 2017 Mar; 41(3):436-445. PubMed ID: 26826259 [TBL] [Abstract][Full Text] [Related]
31. The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells. Megías J; Busserolles J; Alcaraz MJ Br J Pharmacol; 2007 Apr; 150(8):977-86. PubMed ID: 17339836 [TBL] [Abstract][Full Text] [Related]
32. Atrial natriuretic peptide modulates cystic fibrosis transmembrane conductance regulator chloride channel expression in rat proximal colon and human intestinal epithelial cells. Novaira HJ; Ornellas DS; Ortiga-Carvalho TM; Zhang XM; Souza-Menezes J; Guggino SE; Guggino WB; Morales MM J Endocrinol; 2006 Apr; 189(1):155-65. PubMed ID: 16614390 [TBL] [Abstract][Full Text] [Related]
33. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Reiniger N; Lee MM; Coleman FT; Ray C; Golan DE; Pier GB Infect Immun; 2007 Apr; 75(4):1598-608. PubMed ID: 17283089 [TBL] [Abstract][Full Text] [Related]
34. Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Venkatakrishnan A; Stecenko AA; King G; Blackwell TR; Brigham KL; Christman JW; Blackwell TS Am J Respir Cell Mol Biol; 2000 Sep; 23(3):396-403. PubMed ID: 10970832 [TBL] [Abstract][Full Text] [Related]
35. Cellular localization of the cystic fibrosis transmembrane conductance regulator in mouse intestinal tract. Ameen N; Alexis J; Salas P Histochem Cell Biol; 2000 Jul; 114(1):69-75. PubMed ID: 10959824 [TBL] [Abstract][Full Text] [Related]
37. Proliferation, not apoptosis, alters epithelial cell migration in small intestine of CFTR null mice. Gallagher AM; Gottlieb RA Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G681-7. PubMed ID: 11518680 [TBL] [Abstract][Full Text] [Related]
38. Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator. Deschemin JC; Allouche S; Brouillard F; Vaulont S PLoS One; 2015; 10(12):e0145685. PubMed ID: 26709821 [TBL] [Abstract][Full Text] [Related]
39. Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene. Du M; Jones JR; Lanier J; Keeling KM; Lindsey JR; Tousson A; Bebök Z; Whitsett JA; Dey CR; Colledge WH; Evans MJ; Sorscher EJ; Bedwell DM J Mol Med (Berl); 2002 Sep; 80(9):595-604. PubMed ID: 12226741 [TBL] [Abstract][Full Text] [Related]